Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cappelli

Showing results (101-110 of 196) with videos related to

Pageof 20
Sort By:
International Journal of Cardiology|August 1, 2020
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathyMichele Ciabatti, Carlo Fumagalli, Matteo Beltrami, et al.
Aging Clinical and Experimental Research|April 10, 2024
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort studyCarlo Fumagalli, Lucia Ponti, Martina Smorti, et al.
Journal of Cardiac Failure|January 2, 2022
Racial Differences in Val122Ile-Associated Transthyretin Cardiac AmyloidosisJaya Batra, Hannah Rosenblum, Francesco Cappelli, et al.
Clinical Cardiology|February 4, 2015
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosisFrancesco Cappelli, Samuele Baldasseroni, Franco Bergesio, et al.
International Journal of Cardiology|January 14, 2026
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibitionChiara Zocchi, Alessandra Milazzo, Giorgia Panichella, et al.
JACC. Cardiooncology|June 17, 2026
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin AmyloidosisDaniel P Judge, Alan X Ji, Isabella A Graef, et al.
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[State of the art and projects of the Italian Fabry Disease Cardiovascular Registry]Elena Biagini, Giuseppe Limongelli, Vanda Parisi, et al.
JACC. Cardiovascular Imaging|December 23, 2019
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac AmyloidosisMaria Beatrice Musumeci, Francesco Cappelli, Domitilla Russo, et al.
Optics Express|September 23, 2025
Shot-noise-limited emission from interband and quantum cascade lasersTecla Gabbrielli, Jacopo Pelini, Georg Marschick, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
Pageof 20

Showing results (101-110 of 196) with videos related to

Sort By:
Pageof 20
International Journal of Cardiology|August 1, 2020
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathyMichele Ciabatti, Carlo Fumagalli, Matteo Beltrami, et al.
Aging Clinical and Experimental Research|April 10, 2024
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort studyCarlo Fumagalli, Lucia Ponti, Martina Smorti, et al.
Journal of Cardiac Failure|January 2, 2022
Racial Differences in Val122Ile-Associated Transthyretin Cardiac AmyloidosisJaya Batra, Hannah Rosenblum, Francesco Cappelli, et al.
Clinical Cardiology|February 4, 2015
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosisFrancesco Cappelli, Samuele Baldasseroni, Franco Bergesio, et al.
International Journal of Cardiology|January 14, 2026
Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibitionChiara Zocchi, Alessandra Milazzo, Giorgia Panichella, et al.
JACC. Cardiooncology|June 17, 2026
Differential Transthyretin Stabilization in Patients With Wild Type and Variant Transthyretin AmyloidosisDaniel P Judge, Alan X Ji, Isabella A Graef, et al.
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[State of the art and projects of the Italian Fabry Disease Cardiovascular Registry]Elena Biagini, Giuseppe Limongelli, Vanda Parisi, et al.
JACC. Cardiovascular Imaging|December 23, 2019
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac AmyloidosisMaria Beatrice Musumeci, Francesco Cappelli, Domitilla Russo, et al.
Optics Express|September 23, 2025
Shot-noise-limited emission from interband and quantum cascade lasersTecla Gabbrielli, Jacopo Pelini, Georg Marschick, et al.
European Heart Journal|October 7, 2025
Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure AssociationPablo Garcia-Pavia, Esther Gonzalez-Lopez, Lisa J Anderson, et al.
Pageof 20